Prescription Monitoring Act, c. P-15.05
Section 1
Definitions
Cite as Prescription Monitoring Act, c. P-15.05, s. 1 · current to June 6, 2025 · read from New Brunswick Acts and Regulations on November 16, 2026
The text
The following definitions apply in this Act.
“advisory committee” means the Prescription Monitoring Program Advisory Committee established under section 9. (comité consultatif)
“Director” means the Director of the Prescription Monitoring Program appointed under section 5. (directeur)
“dispenser” means an individual who is entitled under an Act of the Legislature to dispense drugs, except an individual who is entitled under the Veterinarians Act to dispense drugs, or a member of a class of individuals prescribed by regulation. (préparateur)
“licensed pharmacist” means an individual who is registered as a pharmacist with the New Brunswick College of Pharmacists and who holds a licence issued under section 31 of the Pharmacy Act. (pharmacien titulaire de permis)
“licensing authority” means the following bodies with statutory responsibility for the discipline of health care providers or to regulate the quality or standards of professional services provided by health care providers: (organisme chargé de la délivrance des permis)
(a) the College of Physicians and Surgeons of New Brunswick;
(b) the Dental Society of New Brunswick;
(c) the New Brunswick College of Pharmacists;
(c.1) the Nurses Association of New Brunswick;
(c.2) the Midwifery Council of New Brunswick;
(c.3) the New Brunswick Association of Optometrists;
(c.4) the New Brunswick Podiatry Association; and
(d) any other body designated by regulation.
“member” , in relation to a licensing authority, means a person who is registered with a licensing authority and who holds a licence issued by that licensing authority. (membre)
“Minister” means the Minister of Health. (ministre)
“monitored drug” means a drug that is in a class of drugs established by the advisory committee. (médicament contrôlé)
“participant” means a prescriber or dispenser registered in the program under section 6. (participant)
“patient monitoring agreement” Repealed: 2025, c.18, s.1
“personal health information” means personal health information as defined in the Personal Health Information Privacy and Access Act. (renseignements personnels sur la santé)
“pharmacy” means a pharmacy with respect to which a valid certificate of accreditation has been issued under the Pharmacy Act, other than a pharmacy designated in the regulations. (pharmacie)
“prescriber” means an individual who is entitled under an Act of the Legislature, an Act of another province or territory of Canada or an Act of the Parliament of Canada to prescribe drugs, except an individual who is entitled under the Veterinarians Act to prescribe drugs or under any similar Act of another province or territory of Canada or of the Parliament of Canada. (prescripteur)
“program” means the Prescription Monitoring Program established under section 3. (programme)
“program information” includes the information submitted under sections 10, 10.1 and 10.2 (renseignements aux fins d’application du programme.)
Read the Prescription Monitoring Act on the Province's website ↗